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Background: Distant metastases stemming from a papillary thyroid carcinoma (PTC) are quite rare. Here we report
an exceptional case of PTC presenting with cervical lymphatic and uterine metastases. This is the first case report of
a PTC with uterine involvement.
Case presentation: A 60-year-old Chinese woman came to our hospital complaining of discomfort in the throat
that she had been experiencing for about half a month. PTC and cervical lymphatic metastasis were diagnosed after
ultrasound examinations. A massive heterogeneous mass was found beside the uterus during the pre-operative
checkup and a diagnosis of ovarian carcinoma was suspected after a thorough case discussion. However, it proved
to be a metastasis from the PTC as determined by pathological and immunohistochemical examinations after the
operation. The patient declined further treatments. She was followed for 22 months with no sign of recurrence
detected.
Conclusions: In this report, an unusual case of PTC was presented. The patient had not only regional lymphatic
metastasis, but also had a massive metastasis in the uterine corpus, which was initially misdiagnosed as ovarian
carcinoma. This case is of interest because of its rarity and exceptionally good prognosis. The reason for the
misdiagnosis was attributed to overlooking the possibility of a distant metastasis coming from a PTC. This case
raises the issue that completing an iodine-131 scan before operating on patients with PTC may be warranted.
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Papillary thyroid carcinoma (PTC) is the most commonly
seen well-differentiated malignancy that generally has a
good prognosis. Regional metastases usually involve cer-
vical and upper mediastinal lymph nodes. Distant metas-
tases, although quite rare, have a profound impact on
survival. The reported 5-year survival rate of PTC patients
operated on for a distant metastasis was approximately
55.0% [1].
A pulmonary metastasis was recognized as the domin-
ant site for a distant metastasis of PTC, followed by
bone [2]. Brain, skin, liver and kidney [3] were seldom
involved and occurrence of a uterine metastasis was
exceptional. We report herein a patient with PTC with
cervical lymphatic metastasis accompanied by uterine* Correspondence: 152081340@qq.com
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A 60-year-old woman presented to our hospital on
September 6, 2011, complaining of discomfort in the
throat that she had been experiencing for about half a
month. Past medical history was not a factor and there
was no family history of thyroid cancer either. Physical
examination revealed a palpable nodule in the right lobe
of the swollen (grade I) thyroid. An ultrasound examin-
ation was performed immediately and an irregular hypoe-
choic nodule (measuring 31 × 15 mm) was detected
arising from the lower pole and extending to the isthmus
of the thyroid. The nodule was solid with blurry margins
(Figure 1A) and it was difficult to distinguish from the tra-
chea. Several coarse calcifications with heavy shadows
were noticed inside. The thyroid capsule was also in-
volved. Two swollen lymph nodes were found besidetd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Ultrasound images of the thyroid nodule and the uterine mass. A. A heterogeneous hypoechoic mass was detected in the
thyroid. The blurred margins are marked by four arrowheads (→). Coarse calcifications with heavy echoic shadow are highlighted by a white
arrow (↑). B. A large mass, containing a sizeable portion of fluid and thick separations, was revealed by ultrasound examination during the
pre-operative checkup.
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13 mm and 14 × 10 mm, respectively. Computed tomog-
raphy (CT) scans of the lungs were done but no positive
findings were noted.
Because invasive thyroid carcinoma with cervical lymph-
atic metastases was assumed, surgical treatment was
scheduled. Before the operation, the patient received a
general checkup, including blood tests, echocardiographic
assessment, abdominal and gynecologic ultrasound ex-
aminations, and CT scans of the head and abdomen. A
heterogeneous mass was found in the right lower quad-
rant behind the uterus. The mass, measuring 115 × 92 ×
94 mm, contained a large quantity of echoic fluid. Thick
separations and two irregular solid components (meas-
uring about 33 × 37 mm and 33 × 21 mm, respectively)
were noticed inside. The ultrasound image is shown in
Figure 1B. Abundant blood flow signals were detected
in the solid components using color Doppler. The out-
side border of the mass was quite clear and smooth, butFigure 2 Pathological images of the thyroid and uterine masses. A pa
is shown in A and B, respectively. Both of them were stained with hemato
papillary growth pattern can be seen in both masses.inside the mass closely adhered to and was difficult to
distinguish from the right wall of the uterus. Neither
ovary was involved. The serum cancer antigen 125
(CA125) level was slightly elevated at 70.58 U/ml (nor-
mal range, 0-35 U/ml). Carcinogenic embryonic antigen
(CEA) (1.97 ng/ml) and CA19-9 (8.82 U/ml) levels were
normal. Given the complex texture of the mass, an
ovarian tumor, probably a cystadenocarcinoma, was sus-
pected. After a thorough discussion with the relatives of
the patient, a second operation following treatment of
the thyroid nodule was scheduled.
A total thyroidectomy and neck exploration were per-
formed on September 17, 2011, under general anesthesia.
Histological examination confirmed the diagnosis of a
well-differentiated PTC (Figure 2A). Immunohistochemi-
cal examination demonstrated that the cells stained posi-
tively for thyroid transcription factor (TTF), cyclin D1,
P27, epidermal growth factor receptor (EGFR) and Ki-67
(ratio 10%), and were negative for cytokeratin 19. Regionalthological image of the heterogeneous mass in the thyroid and uterus
xylin and eosin and the image was magnified 40 times. The classical
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had an uneventful postoperative course and was dis-
charged on the 7th postoperative day.
Fifteen days later she returned to our department of
gynecology for further treatment of the abdominal mass.
An abdominal exploration was performed and a large
pink mass was detected arising from the posterior wall
of the uterus. The mass was soft and covered by the ser-
osa of the uterus. Both ovaries were easily identified be-
cause they were separated from the uterus and had a
normal appearance. No ascites was found in the pouch
of Douglas. A total abdominal hysterectomy along with
bilateral salpingo-oophorectomy, omentectomy and a
periaortic lymph node biopsy were performed while tak-
ing into consideration the age of the patient. On gross
sections, several cysts were revealed that were filled
with brown fluid inside the large heterogeneous mass.
The two irregular solid components shown on the sono-
grams were also seen on the inside wall of the mass, and
both of them had a gray and granular surface. No evi-
dence of malignant changes was detected in tissue slices
taken from the ovaries.
Postoperative pathological results were available five days
later, and the diagnosis of a uterine metastasis stemming
from the PTC was suspected (Figure 2B). To rule out a pri-
mary uterine carcinoma, an immunohistochemical assay
on an appropriate panel of proteins was performed. The
heterogeneous mass showed strong expression of TG,
CK7, CAM5.2 and TTF. Results for CA125, EMA and
CD10 were negative. Therefore, the diagnosis of metastatic
PTC in the uterine corpus was established. No positive
findings resulted from the harvested lymph nodes. The
clinical course following surgery was indolent; the patient
was discharged on October 14, 2011. Just prior to being
discharged, she accepted to undergo a general radioactive
iodine scan, and no abnormal hotspots were found. For
unclear reasons, the patient declined further treatments
and follow-up was suggested. Since then, she has returned
three times for general checkups and once for a PET-CT
examination, and thus far no signs of recurrence have
been detected.
Discussion
The uterus, mostly composed of smooth muscle tissue,
has rarely been identified as a metastatic site of extrage-
nital primary cancers [4]. When this occurs, the ovaries
and endometrium are most often affected (75-80% of the
cases), with breast and gastrointestinal carcinomas [5,6]
being the most common primary extragenital cancers.
PTC, which corresponds to approximately 65-80% of
thyroid tumors, is usually confined to the gland or tends
to metastasize locally to mainly regional lymph nodes
[7]. Distant metastasis of PTC is rare, but of the utmost
importance for the patient, as the impact on prognosis issubstantial. According to the literature, the most fre-
quent sites for PTC distant metastases are lungs (72-
76% of cases), mediastinum (24%) and bones (19-23%),
while there are only sporadic reports of distant spread to
other locations. Dr. Kumar described a case of medullary
thyroid cancer with a uterine metastasis, but no detailed
clinical or radiological information was provided [8].
Here, we have described a rare and perhaps the first case
of a PTC metastasis restricted to the uterine corpus
without involving the ovaries.
The patient had no obvious gynecologic symptoms
when she came to our hospital. The metastatic mass was
detected during a pre-operative checkup. On sonograms,
it was heterogeneous with thick separations and solid
components, mimicking an ovarian mucinous cystadeno-
carcinoma. Because of the patient’s age and the shielding
afforded by the large mass, neither ovary was detected be-
fore the operation. Consequently, the mass was at first
misdiagnosed as an ovarian cancer. Considering the vol-
ume of the mass, all participants in the treatment group
agreed that the uterine metastasis most probably occurred
much earlier than the detection of the thyroid nodule. The
potential mechanism that could account for this was dis-
cussed. As there were no abnormal hot spots found on the
radioactive iodine scan after the second operation, and no
positive findings in the harvested abdominal lymph nodes,
we believe that the metastasis was hematogenously dis-
seminated. Though very rare, the possibility of malignant
transformation of the struma uteri [9] was also proposed
and then retracted because no normal thyroid tissue was
found in the tumor or in the corpus of the uterus.
In terms of treatment for patients with PTC who have
distant metastases, no standard protocol has been pro-
posed. It was reported that radioiodine ablation cures only
7% of patients with bone metastases [10]. Researchers pos-
tulated that metastases from a differentiated thyroid can-
cer may not concentrate radioactive iodine because the
cells were more immature than the original thyroid neo-
plasm. Here, the patient accepted only surgical resection
of the tumor and hence, no further treatments were per-
formed. Despite this, the patient has already lived an add-
itional 22 months post-surgery with no sign of recurrence.
We attribute the good prognosis to the high degree of dif-
ferentiation of the primary carcinoma.
Conclusions
To our knowledge, this is the first case report of a PTC
with synchronous secondary uterine involvement. This
case raises a discussion on dealing with differential diag-
nostic problems in the setting of clinical and pathological
investigations of patients with PTC. The possibility of a
uterine metastasis, as described here, may warrant com-
pleting an iodine-131 scan before operating on patients
with PTC.
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